Soluble CR1 and its potential as a therapy for C3 glomerulopathy

Abstract

Peer reviewed

C. Nester, Y. Yang, D. Holanda, H. Marsh, R. Hammond, L. Thomas, S. Sethi and R.J.H. Smith

Molecular immunology, Vol.56(3), pp.293-293

12/15/2013

DOI: 10.1016/j.molimm.2013.05.150

View Online

Title: Subtitle: Soluble CR1 and its potential as a therapy for C3 glomerulopathy
Creators: C. Nester - University of Iowa
Y. Yang - University of Iowa
D. Holanda - University of Iowa
H. Marsh - Celldex Therapeutics
R. Hammond - Celldex Therapeutics
L. Thomas - Celldex Therapeutics
S. Sethi - Mayo Clinic
R.J.H. Smith - University of Iowa
Resource Type: Abstract
Publication Details: Molecular immunology, Vol.56(3), pp.293-293
Publisher: Elsevier Ltd
DOI: 10.1016/j.molimm.2013.05.150
ISSN: 0161-5890
eISSN: 1872-9142
Language: English
Date published: 12/15/2013
Academic Unit: Pathology; Molecular Physiology and Biophysics; Roy J. Carver Department of Biomedical Engineering; Internal Medicine; Anatomy and Cell Biology; Iowa Neuroscience Institute; Otolaryngology; Stead Family Department of Pediatrics; Nephrology, Dialysis and Transplantation
Record Identifier: 9984354502902771

22 Record Views